Meet with us at
September 18-19, 2024
The mRNA industry is experiencing a new wave of innovation, with the development of cancer vaccines, emerging therapeutics, and novel gene editing tools. Yet, the speed, cost of production, and limited flexibility to improve current processes remain significant challenges that hinder and slow the development of these promising therapeutics.
Deep dive into three days of content, carefully designed to help you implement high-throughput process development, optimize mRNA synthesis and purification, develop process analytics and optimize drug product formulation to unlock the unlimited potential of mRNA for all applications.
Stop by Curia's Booth: TBD
Curia is a Contract Development and Manufacturing Organization with over 30 years of experience, an integrated network of 27 global sites and over 3,500 employees partnering with customers to make treatments broadly accessible to patients. Our biologics and small molecule offering spans discovery through commercialization, with integrated regulatory and analytical capabilities. Our scientific and process experts and state-of-the-art facilities deliver best-in-class experience across drug substance and drug product manufacturing. From curiosity to cure, we deliver every step to accelerate and sustain life-changing therapeutics.
To learn more visit us at curiaglobal.com
AMRI, a global contract research and manufacturing organization, partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life. With locations in North America, Europe and Asia, AMRI’s team combines scientific expertise and market-leading technology to provide a complete suite of solutions in Discovery, Development, Analytical Services, API Manufacturing and Drug Product. We’ve got it down to an exact science.